HbA1c Pitfalls: When the Number Lies

 

HbA1c Pitfalls: When the Number Lies

Hemoglobinopathies, iron deficiency, CKD, and transfusions all break A1c. Here's when to trust it and when to use alternatives.

HbA1c is the cornerstone of diabetes diagnosis and monitoring. But it measures glycated hemoglobin, which means anything that alters hemoglobin or RBC lifespan will alter the A1c—independent of blood glucose. In your patients with sickle cell trait, iron deficiency, chronic kidney disease, or recent transfusions, the A1c may be telling you a completely different story than what their glucometer shows.

How A1c Works (and Why It Breaks)

A1c measures the percentage of hemoglobin A molecules with glucose attached. It reflects average blood glucose over the preceding 2–3 months (the lifespan of an RBC). This works perfectly when RBC lifespan and hemoglobin structure are normal. When they're not, the test becomes unreliable.

Conditions That Falsely LOWER A1c

These conditions shorten RBC lifespan or increase RBC turnover, giving glucose less time to glycate hemoglobin:

• Hemolytic anemias (autoimmune, G6PD deficiency, hereditary spherocytosis, sickle cell disease)
• Chronic kidney disease (especially on EPO therapy—accelerated erythropoiesis produces younger RBCs)
• Recent blood transfusion (dilutes the patient's glycated hemoglobin with donor RBCs)
• Acute or chronic blood loss (reticulocytosis = younger RBCs)
• Splenomegaly (increased RBC destruction)
• Pregnancy (hemodilution + increased RBC turnover, especially 2nd/3rd trimester)
• Hemoglobin variants: HbS (sickle), HbC, HbE can interfere with some assay methods (though newer methods handle this better)

Clinical Impact

A patient with sickle cell trait and a "normal" A1c of 5.8% may actually have diabetes. A patient on dialysis with an A1c of 6.0% may have average glucoses much higher than 126 mg/dL. If the A1c doesn't match the home glucose readings or clinical picture, suspect interference.

Conditions That Falsely RAISE A1c

These conditions extend RBC lifespan or otherwise increase glycation time:

• Iron deficiency anemia (the most common cause of falsely elevated A1c—iron-deficient RBCs live longer and accumulate more glycation)
• B12/folate deficiency (impaired erythropoiesis = older circulating RBCs)
• Splenectomy (RBCs not being cleared as quickly)
• Alcoholism (forms acetaldehyde-hemoglobin adducts that some assays measure as A1c)
• Chronic opioid use (reported association with falsely elevated A1c)
• Hypertriglyceridemia (can interfere with some assay methods)

The Iron Deficiency Trap

This one trips up NPs constantly. A patient with untreated iron deficiency anemia may have an A1c of 6.8%—technically "diabetic"—that drops to 5.5% after iron repletion. Always check for and correct iron deficiency before diagnosing diabetes based on A1c alone. This is especially important in menstruating women and patients with celiac disease or chronic GI blood loss.

When to Use Alternatives to A1c

Alternative Test	What It Measures	When to Use
Fructosamine	Glycated serum proteins (mainly albumin); reflects 2–3 week average glucose	Hemoglobinopathies, recent transfusion, dialysis, any condition making A1c unreliable. Not useful in hypoalbuminemia (nephrotic syndrome, cirrhosis).
Glycated albumin	Similar to fructosamine; 2–3 week average	Same indications as fructosamine; may be slightly more standardized
CGM (Continuous Glucose Monitoring) data	Real-time and ambulatory glucose profiles; calculates GMI (Glucose Management Indicator)	The gold standard when A1c is unreliable. Provides time in range, variability, and hypoglycemia data. Increasingly accessible.
Fasting glucose / OGTT	Point-in-time or 2-hour post-load glucose	For initial diabetes diagnosis when A1c is suspect; OGTT is the gold standard for gestational diabetes

Ethnic and Genetic Variation

A1c levels can vary by race and ethnicity independent of glucose levels. African American, Hispanic, and Asian patients tend to have A1c values 0.3–0.4% higher than White patients at the same average glucose. This is partially explained by differences in hemoglobin glycation rates and RBC survival. Current diagnostic thresholds (6.5% for diabetes) apply uniformly, but this variation may contribute to diagnostic disparities.

The Pitfalls Summary

• Diagnosing diabetes by A1c alone in a patient with iron deficiency: Correct the iron first, then recheck.
• Trusting A1c in sickle cell disease/trait: Use fructosamine or CGM data instead.
• Monitoring A1c in dialysis patients: A1c underestimates glucose control; use glycated albumin or CGM.
• Post-transfusion A1c: Wait at least 3 months after transfusion for a reliable A1c.
• A1c discordant with home glucose logs: Always investigate—interference from one of the conditions above, or inaccurate glucometer readings, or selective testing by the patient.
• Using A1c for gestational diabetes diagnosis: A1c is NOT recommended for GDM screening. OGTT is the standard.

Bottom Line

A1c is a powerful tool when hemoglobin and RBC lifespan are normal. In patients with hemoglobinopathies, iron deficiency, CKD, hemolysis, or recent transfusion, it lies—sometimes enough to misdiagnose or under-treat diabetes. Know the conditions that raise it falsely (iron deficiency is #1), know the conditions that lower it falsely (hemolysis and CKD), and use fructosamine or CGM when A1c can't be trusted.

Stay sharp out there.